|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Saturn V Capital Management LP
✚
|
|
|---|---|
| CRD # | 316649 |
| SEC # | 801-128448 |
| CIK # | 0001964437, 0001883601 |
| AUM | $424.2 M (2025-04-21) |
| Employees | 4 (75% Investors, 0% Brokers) |
| Phone | 415-738-4435 |
| Address | 919 Congress Avenue Austin, TX 78701 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001964437 0001883601 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Jazz Pharmaceuticals Inc | 22.0 | ||
| FS Development Corp | 21.0 | ||
| Amylyx Pharmaceuticals Inc | 20.9 | ||
| Vaxcyte Inc | 17.7 | ||
| UNUM Therapeutics Inc | 16.5 | ||
| Celcuity Inc | 15.8 | ||
| CG Oncology Inc | 15.3 | ||
| Xenon Pharmaceuticals Inc | 14.7 | ||
| Dyne Therapeutics Inc | 13.9 | ||
| Helix Acquisition Corp | 13.7 | ||
| Merus NV | 11.8 | ||
| Centessa Pharmaceuticals PLC | 10.4 | ||
| Graphite Bio Inc | 10.0 | ||
| Neurocrine Biosciences Inc | 7.3 | ||
| Ocular Therapeutix Inc | 6.8 | ||
| Ascendis Pharma A/S | 6.6 | ||
| Argenx SE | 5.7 | ||
| Abivax Sa | 4.8 | ||
| Syndax Pharmaceuticals Inc | 4.7 | ||
| Newamsterdam Pharma Co NV | 4.0 | ||
| Contineum Therapeutics Inc | 1.3 | ||
| Replimune Group Inc | 1.2 | ||
| Carbylan Therapeutics Inc | 0.7 | ||
| Silence Therapeutics PLC | 0.2 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Blackwell Partners LLC - Series A | 2022-02-23 | 189.1 | |
| HF | Saturn V Capital LP | [2022-02-23] | 150.0 | 235.2 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 424.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 424.2 |
| By Discretionary | ||
| Discretionary | 3 | 424.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 424.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 35.8 | |
| United States Persons | 388.4 | |
| Total | 3 | 424.2 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Saturn V Capital Management LP | 2 | ||
| Xiaoying Tian | 2 | ||
| Saturn V Capital Management LLC | 2 | ||
| Saturn V Capital GP LLC | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| D | [0001883601] | |
| 13F-HR | [0001964437] | |
| SC 13G | [0001964437] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Saturn V Capital Management LP | KalVista Pharmaceuticals Inc | [2024-02-12] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Brightlight Capital Management LP
✚
|
CT | 0.4 |
|
White Oaks Investment Management Inc
✚
|
FL | 0.4 |
|
Greenstone Partners LLC
✚
|
CA | 0.4 |
|
Palo Duro Investment Partners LP
✚
|
IL | 0.4 |
|
Makaira Partners LLC
✚
|
CA | 0.4 |
|
Ogborne Capital Management LLC
✚
|
CA | 0.4 |
|
First Sabrepoint Capital Management LP
✚
|
TX | 0.4 |
|
FIO Advisors LP
✚
|
NY | 0.4 |
|
Armor Advisors LLC
✚
|
NY | 0.4 |
|
Spark Investment Management LLC
✚
|
NY | 0.4 |